Roche has selected PathAI to collaborate with it on an artificial intelligence program that will be merged with its digital pathology work.
Roche has selected PathAI to collaborate with it on an artificial intelligence program that will be merged with its digital pathology work.
Automated chemistry has been a priority for many companies since the outbreak of the pandemic. Paul Whittles is the sales director at Deepmatter Group (a company based in Glasgow, UK